Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-032685
Filing Date
2020-12-03
Accepted
2020-12-03 18:07:34
Documents
2
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2738
2 EX-24 DOCUMENT attachment1.htm EX-24 4312
  Complete submission text file 0000899243-20-032685.txt   8420
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ASSERTIO THERAPEUTICS, INC. 100 SOUTH SAUNDERS ROAD, SUITE 300 LAKE FOREST IL 60045
Business Address
Wheadon David E. (Reporting) CIK: 0001789507 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38958 | Film No.: 201367983